| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eac3c49e8f0c8f16778210daffa59c95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54b784d69acf12516279160a8713c243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_424cd1f6da71acd523dc8e89085b92ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1ce4c30b598337f752ddf3679f62792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ceac749bcf14dd643054e7c657965af8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate |
2008-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8097387e09fe9e2121573c2938d4e2b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2262e242a6ca3a8d682e64f73e4db6fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f60e1e573fe4313e5dedfac2488b303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a649885b1f7a709d59ae7534342f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5c77dca80105d9fbc62d04e8dcd4b30 |
| publicationDate |
2009-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009012005-A1 |
| titleOfInvention |
Use of an angiotensin IV antagonist to treat insulin resistance or cardiovascular risk related to metabolic syndrome |
| abstract |
The present invention relates to the use of an angiotensin IV antagonist that decreases the effects on angiotensinogen expression of angiotensin IV in vascular smooth muscle cells for preparing a drug to treat or prevent type II diabetes, insulin resistance or cardiovascular risk related to metabolic syndrome, as well as to pharmaceutical compositions comprising one such antagonist. |
| priorityDate |
2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |